Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 25, 2000

View Archived Issues

Eurand expands drug delivery capabilities

NIAID signs agreement with MVI/PATH for malaria vaccine research

Pig small intestine submucosa shows efficacy in wound healing

Aquila receives milestone payments under licensing agreements

NK1 receptor antagonist CP-99994 tested in ferret model of emesis

Oxford BioMedica to collaborate with AstraZeneca in drug discovery

Phase III results positive for memantine in AD

New Videx capsule formulation approved in France

Nastech's intranasal apomorphine compared to Viagra in phase II pilot trial

Magainin to begin clinical program for squalamine in genetic bone disorder

Buccal insulin/metformin combination therapy tested in type II diabetes

SciClone awarded grant to study novel immunomodulator in TB

Combidex NDA accepted for FDA review

PathoGenesis announces approval, distribution agreement for TOBI

Abbott launches new sedative for ICU use only

Use of FK-506 as topical analgesic disclosed

Cytotoxic artemisinin derivatives designed at Hong Kong U. of Science & Technology

U. of Texas designs new DNA-cleaving compounds

Antianginal agents with minimal arrhythmogenic potential developed at Lafon

Small-molecule transthyretin amyloid fibril inhibitors emerge from structure-based design program

Kinetix enters research collaboration with Dana-Farber Cancer Institute

Beijing-based researchers discover new antitumor indole derivatives

Allergan and Dura enter commercialization agreement for multiple products

Antiplatelet agents under study at Chinese centers

BIBN-4096BS: an extremely potent and selective CGRP antagonist for migraine

Second orphan drug designation granted for Maxamine

Selective 5-HT1D agonist L-775606 has reduced coronary vasoconstrictor effects vs. sumatriptan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...